CoreFill Plus Deep Lidocaine (1x1.1ml)

Patients should refrain from consuming alcohol for at least 24 hours before and 48 hours after the procedure. As a vasodilator, alcohol increases blood flow to the treatment site, which can significantly exacerbate post-filler swelling and increase the visibility of injection-site bruising.

Injection is not recommended for nursing mothers. It is advised to wait until the breastfeeding period has concluded to ensure the highest safety for both the mother and the infant during elective aesthetic treatments.

The formulation contains 24 mg/ml of cross-linked Hyaluronic Acid of non-animal origin, supplemented with 0.3% Lidocaine hydrochloride to ensure procedural comfort.

Dosage is individualized based on the patient's anatomical needs and the depth of the cutaneous depression. A single 1.1 ml syringe is typically sufficient for a full lip augmentation or the correction of bilateral nasolabial folds. Practitioners should evaluate if 0.5 ml of lip filler is enough for the patient's specific hydration goals before using the full 1.1 ml volume.

Common post-injection reactions include transient swelling, localized tenderness, and potential purple bruising. These are standard following any mucosal HA injection. To ensure an optimal recovery, patients should strictly follow our expert aftercare guide. Any persistent blanching or intense pain must be evaluated immediately for vascular occlusion.

The cross-linked HA matrix binds water molecules within the dermal layers to provide immediate mechanical volume. Unlike superficial skin boosters, CoreFill Plus Deep is designed for mid-to-deep dermal support, resisting premature enzymatic degradation to maintain structural correction for longer periods.

This treatment is strictly contraindicated during pregnancy. There is no clinical safety data regarding the use of cross-linked HA and lidocaine on fetal development. We prioritize safety standards and advise postponing all elective fillers until after childbirth.